Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury

Yi Wang,Xiaolong Fu,Li Zeng,Yan Hu,Rongyang Gao,Siting Xian,Songjie Liao,Jianxiang Huang,Yonggang Yang,Jilong Liu,Hai Jin,James Klaunig,Yuanfu Lu,Shaoyu Zhou
DOI: https://doi.org/10.1038/s42003-024-06243-0
IF: 6.548
2024-05-24
Communications Biology
Abstract:Nuclear factor erythroid 2-related factor-2 (Nrf2) antioxidant signaling is involved in liver protection, but this generalization overlooks conflicting studies indicating that Nrf2 effects are not necessarily hepatoprotective. The role of Nrf2/heme oxygenase-1 (HO-1) in cholestatic liver injury (CLI) remains poorly defined. Here, we report that Nrf2/HO-1 activation exacerbates liver injury rather than exerting a protective effect in CLI. Inhibiting HO-1 or ameliorating bilirubin transport alleviates liver injury in CLI models. Nrf2 knockout confers hepatoprotection in CLI mice, whereas in non-CLI mice, Nrf2 knockout aggravates liver damage. In the CLI setting, oxidative stress activates Nrf2/HO-1, leads to bilirubin accumulation, and impairs mitochondrial function. High levels of bilirubin reciprocally upregulate the activation of Nrf2 and HO-1, while antioxidant and mitochondrial-targeted SOD2 overexpression attenuate bilirubin toxicity. The expression of Nrf2 and HO-1 is elevated in serum of patients with CLI. These results reveal an unrecognized function of Nrf2 signaling in exacerbating liver injury in cholestatic disease.
biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the role of nuclear factor erythroid 2 - related factor 2 (Nrf2) and heme oxygenase - 1 (HO - 1) signaling pathways in cholestatic liver injury (CLI). Although Nrf2 is generally considered to have antioxidant protection, this study reveals that under cholestatic conditions, the activation of Nrf2/HO - 1 actually exacerbates liver injury rather than providing protection. Specifically, the study found that: - Activation of the Nrf2/HO - 1 signaling pathway leads to excessive bilirubin accumulation and impairs mitochondrial function, thereby aggravating CLI. - Inhibition of HO - 1 or improvement of bilirubin transport can alleviate liver injury in CLI models. - In non - CLI mice, Nrf2 knockout aggravates liver injury, but in CLI mice, Nrf2 knockout can provide liver protection. - High levels of bilirubin form a vicious cycle by reverse - regulating the activation of Nrf2 and HO - 1, promoting the pathological development of CLI. These findings reveal the unrecognized function of the Nrf2 signaling pathway in cholestatic diseases, that is, it may exacerbate liver injury by increasing bilirubin levels, which provides a potential intervention target for the clinical treatment of cholestatic liver diseases.